Neutralization of MERS coronavirus through a scalable nanoparticle vaccine

MERS-CoV continues to cause human outbreaks, so far in 27 countries worldwide following the first registered epidemic in Saudi Arabia in 2012. In this study, we produced a nanovaccine based on virus-like particles (VLPs). VLPs are safe vaccine platforms as they lack any replication-competent genetic...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	npj vaccines Jg. 6; H. 1; S. 107 - 9
Hauptverfasser:	Mohsen, Mona O., Rothen, Dominik, Balke, Ina, Martina, Byron, Zeltina, Vilija, Inchakalody, Varghese, Gharailoo, Zahra, Nasrallah, Gheyath, Dermime, Said, Tars, Kaspars, Vogel, Monique, Zeltins, Andris, Bachmann, Martin F.
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	London Nature Publishing Group UK 24.08.2021 Nature Publishing Group Nature Portfolio
Schlagworte:	631/250 631/250/590/2294 Biomedical and Life Sciences Biomedicine E coli Hepatitis Infectious Diseases Medical Microbiology Middle East respiratory syndrome Neutralization Public Health Toxins Vaccine Vaccines Virology
ISSN:	2059-0105, 2059-0105
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!